Trial intelligence / Profile preview

PET-CT Assessment of Radiation-Induced Cardiotoxicity in Locally Advanced NSCLC

NCT07761910Phase 2Recruiting

Sponsor
Indiana University
Start
Sep 2026
Primary completion
Jul 2027
Countries
1
01

Overview

A Phase 2 trial of Flurpiridaz F 18, sponsored by Indiana University. Started Sep 2026; status: recruiting.

02

Drugs

Flurpiridaz F 18

Beyond the preview

Go deeper on NCT07761910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07761910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call